Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Dicerna Pharmaceutic (DRNA)

11.95 0.45 (3.91%)

02-22 16:00

Open:

11.51

Pre. Close:

11.5

High:

12.14

Low:

11.395

Volume:

631,249

Market Cap:

617M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.154 - 12.202

12.202 - 12.244

Low:

11.272 - 11.329

11.329 - 11.378

Close:

11.848 - 11.944

11.944 - 12.027

Technical analysis  (as of: 2018-02-22 5:00:53 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 14.39     One year: 16.81

Support:

Support1: 10.01    Support2: 8.59

Resistance:

Resistance1: 12.32    Resistance2: 14.39

Pivot:

10.03

Moving Averages:

MA(5): 11.19     MA(20): 10.02

MA(100): 8.16     MA(250): 5.24

MACD:

MACD(12,26): 0.57     Signal(12,26,9): 0.34

%K %D:

%K(14,3): 87.06     %D(3): 86.64

RSI:

RSI(14): 70.52

52-Week:

High: 12.32  Low: 2.52  Change(%): 328.3

Average Vol(K):

3-Month: 36305  10-Days 38550

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
DRNA has closed above the upper band by 0.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 39% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 19 Feb 2018 15:00:00 GMT
Dicerna Pharmaceuticals: Institutional Buying Heats Up

Tue, 19 Dec 2017 17:05:20 GMT
Dicerna Pharmaceuticals: Buy The Dip

Sat, 04 Nov 2017 00:22:30 GMT
Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q3 2017 Results ...

Tue, 09 May 2017 00:22:30 GMT
Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q1 2017 Results ...

Tue, 16 Jan 2018 14:05:15 GMT
Premarket analyst action - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

51.64

Shares Float (M)

51.38

% Held by Insiders

% Held by Institutions

64.10

Shares Short (K)

335

Shares Short Prior Month (K)

380

Stock Financials

EPS

-3.430

EPS Est. Current Year

-2.700

EPS Est. Next Year

-2.760

EPS Est. Next Quarter

-0.690

Forward EPS

-3.108

Book Value (p.s.)

8.470

PEG Ratio

Profit Margin

Operating Margin

-5936.89

Return on Assets (ttm)

-96.1

Return on Equity (ttm)

-276.0

Qtrly Rev. Growth

192.6

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.121

Qtrly Earnings Growth

Operating Cash Flow (M)

-50.96

Levered Free Cash Flow (M)

-29.50

atoplab.com

Valuation

P/E

-3.48

P/E Growth Ratio

0.04

P/BV

1.41

P/S

12341959680.00

P/CF

-12.11

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.